1. Medtech Insight

FDA Warning Letter Recap, October 2021: Maker Of Blood Collection Device Cited For Quality System Violations

 
• By Shawn M. Schmitt

The warning letter to the Seattle-based company was the product of six-week in-person inspection that stretched from June to July. A total of five device-related missives were released by the US agency last month.

Warning Rubber Stamp

Checkout MedtechInsight'sUSFDAWarningLetterDataTracker here.

This chart lists device-related warning letters released by the US Food and Drug Administration in October 2021. If an inspection...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from US FDA Warning Letters

More from Compliance